Table 1.

Activity values for VWF and FVIII in heterozygous VWD and normal dogs treated with either rhIL-11 or DDAVP



rhIL-11

DDAVP
Heterozygous VWD
Normal*
Heterozygous VWD
Normal*

VWF
FVIII
VWF
FVIII
VWF
FVIII
VWF
FVIII
Baseline   100 (34)   100 (69)   100 (61)   100 (39)   100 (46)   100 (77)   100 (85)   100 (45)  
Day 1   146 (50)   144 (99)   121 (74)   92 (36)   160 (73)   162 (125)   239 (203)   172 (78)  
Day 5   244 (83)   138 (95)   261 (159)   163 (64)   204 (93)   167 (129)   146 (125)   126 (57)  
Day 7   294 (100)   178 (123)   320 (194)   244 (95)   126 (57)   131 (101)   125 (107)   104 (47)  
Day 14
 
134 (48)
 
100 (69)
 
94 (57)
 
98 (38)
 
117 (54)
 
190 (147)
 
110 (93)
 
104 (47)
 


rhIL-11

DDAVP
Heterozygous VWD
Normal*
Heterozygous VWD
Normal*

VWF
FVIII
VWF
FVIII
VWF
FVIII
VWF
FVIII
Baseline   100 (34)   100 (69)   100 (61)   100 (39)   100 (46)   100 (77)   100 (85)   100 (45)  
Day 1   146 (50)   144 (99)   121 (74)   92 (36)   160 (73)   162 (125)   239 (203)   172 (78)  
Day 5   244 (83)   138 (95)   261 (159)   163 (64)   204 (93)   167 (129)   146 (125)   126 (57)  
Day 7   294 (100)   178 (123)   320 (194)   244 (95)   126 (57)   131 (101)   125 (107)   104 (47)  
Day 14
 
134 (48)
 
100 (69)
 
94 (57)
 
98 (38)
 
117 (54)
 
190 (147)
 
110 (93)
 
104 (47)
 

VWF activity by botrocetin-based bioassay and FVIII activity by Coamatic are reported as percentage of baseline. Actual values are shown in parentheses. Measurements were made at 30 minutes after treatment on days 1, 5, and 7 and at a comparable time on day 14.

*

Average of 2 normal dogs.

Close Modal

or Create an Account

Close Modal
Close Modal